Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
Alberta Stroke Program Early CT score
algorithm
amaurosis fugax
andexanet
aneurysm
aneurysm, anterior communicating
aneurysm, internal carotid artery
aneurysm, intracranial
aneurysm, intracranial, delayed cerebral ischemia with
aneurysm, intracranial, treatment of
aneurysm, middle cerebral artery
aneurysm, multiple intracranial
aneurysm, vertebral basilar system
angiography, cerebral
anticholesterolemic agents in treatment of C.V.D.
anticoagulant, complications of
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
aortoiliac reconstruction
arterial dissection
arteritis, temporal
aspirin
asymptomatic
basal ganglia, hemorrhage
blood pressure
blood pressure, control
brain scan
bruit
bruit, asymptomatic
calcium antagonist
carotid artery disease
carotid artery occlusion, neck
carotid artery stenosis
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, cerebrovascular disease
CAT scan, dense artery sign
CAT scan, mass effect on
CAT scan, perfusion
cerebellar hemorrhage
cerebral atherosclerosis
cerebral blood flow
cerebral embolism
cerebral embolism, cardiac origin
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral ischemia, pathogenesis of
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, classification
cerebrovascular accident, complications with
cerebrovascular accident, delay in treatment
cerebrovascular accident, etiology
cerebrovascular accident, nontreatment of
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time to treatment
cerebrovascular disease
cerebrovascular disease, cardiovascular disease with
cerebrovascular disease, hypercholesterolemia in
cerebrovascular disease, predisposed factor in
cerebrovascular disease, smoking in
cerebrovascular disease, surgical treatment of
cerebrovascular disease, treatment of
ciraparantag
collateral circulation
complications
controversies in neurology
coronary artery bypass
coronary thrombolysis
coumarin
craniectomy, decompressive
critical care unit
dabigatran
danaproid
dense middle cerebral artery sign
dextran
diabetes mellitus
dipyridamole
disability, neurological
do not resuscitate
echoencephalogram
electroencephalogram
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endovascular therapy
endovascular therapy, futile interhospital transfer
endovascular therapy, selection criteria
ENRICH trial
epidemiology of neurology
excitotoxin
factor Xa inhibitor
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
gastrointestinal bleeding
Glasgow coma score
glutamic acid
head injury
headache
hemodynamics, regional after stroke
hemostatic therapy
heparin
heparin, low-molecular-weight
heparinoid, low molecular weight
herniation syndromes, intracranial
hydrocephalus
hyperglycemia
hypertension
iatrogenic neurologic disorders
idarucizumab
incidence
INR values
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, incidence of
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, multiple
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, progression of
intracerebral hemorrhage, recurrent
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure monitoring
intracranial pressure, increased
intravascular volume expansion
intraventricular hemorrhage
intraventricular hemorrhage, clot evacuation
intraventricular hemorrhage, treatment
intubation
ischemic penumbra
life support, withdrawal of
life support, withholding of
lumbar puncture
lumbar puncture, complications of
malformation, vascular
malformation, vascular, cerebral
malformation, vascular, treatment of
Marfan syndrome
metabolic change after ischemic cerebral infarct
middle cerebral artery, occlusion of
minimally invasive surgery
mortality
MRI, CAT scan compared to
multimodal neuroimaging
myocardial infarction
myocardial infarction, acute
neurologic disease, diagnoses of
neurologic examination
neurological intensive care
neuroprotective agents
NIH stroke scale
NMDA antagonists
non-vitamin K antagonist oral anticoagulants
old age, neurology of
ophthalmodynamometry
orthostatic hypotension
patient selection
platelet inhibiting drugs
postpartum cerebral angiopathy
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
prothrombin complex concentrate
prothrombin time
prothrombin time, prolonged
race
RAPID CT perfusion maps
recombinant activated factor VII
review article
risk factors
seizure
seizure, prevention of
small vessel disease
Spot sign
steroid
steroid therapy, CNS treatment and complications with
streptokinase
stroke center
stroke protocol
stroke, completed
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
subdural hematoma
superficial temporal-middle cerebral artery anastomosis
syncope
thrombectomy
thrombocytosis
thrombolysis, mechanical
thrombosis, cerebral
ticlopidine
time is brain
tissue plasminogen activator, intravenous
tranexamic acid
transient global amnesia
transient ischemic attack
transient ischemic attack, crescendo
transient ischemic attack, treatment of
transport of patient
treatment of neurologic disorder
vasculopathy
vasodilating agents in treatment of cerebrovascular disease
vasospasm, cerebral
ventriculostomy
ventriculostomy, endoscopic
vertebral-basilar insufficiency
vitamin K
workup
Showing articles 350 to 400 of 10905 << Previous Next >>

Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025

Use and Eligibility for Glucose-Like Peptide-1 Receptor Agonist Treatment for Primary Preveention of Stroke
Neurol 104:e213739, Wilson,L.M. & Anderson,T.S., 2025

Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025

A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025

Risk of Dementia in Individuals with Emergency Department Visits or Hospitalizations Due to Cannabis
JAMA Neurol 82:570-579, Myran,D.T.,et al, 2025

Aspirin Continuation or Discontinuation in Surgically Treated Chronic Subdural Hematoma, A Randomized Clinical Trial
JAMA Neurol 82:551-559, Kamenova,M.,et al, 2025

Bobble-Head Doll Syndrome in a Child
Neurol 104: e213694, Chityala,A.,et al, 2025

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025

Myasthenia Gravis - Redemption for B-Cell Depletion
NEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025

Efficacy and Safety of Selimetinib in Adults with Neurofibromatosis Type 1 and Symptomatic, Inoperable Plexiform Neurofibromas (KOMET): A Multcentre, International, Randomised Placebo-Controlled, Parallel, Double-Blind, Phase 3 Study
Lancet 405:2217-2230, Chen,A.P.,et al, 2025

Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025

Disease-Modifying, Neuroprotective Effect of N-Acetyl-L-Leucine in Adult and Pediatric Patients with Neimann-Pick Disease Type C
Neurol 105:e213589, Patterson,M.C., et al, 2025

Intravenous Tenecteplase before Thrombectomy in Stroke
NEJM 393:139-150, Qiu,Z.,et al, 2025

Left Atrial Appendage Occlusion and Its Role in Stroke Prevention
Stroke 56:1928-1937, Seiffge,D.J.,et al, 2025

Intra-Arterial Thrombolysis Following Endovascular Recanalization for Large Vessel Occlusion Stroke
Neurol 105: e213842, Jiang,X.,et al, 2025

Clinicopathological Conference, Powasan Virus Encephalitis
NEJM 393:176-184, Case 19-2025, 2025

AAV9-Mediated Gene Therapy for Infantile-Onset Pompes Disease
NEJM 392:2438-2446, 2477, Ma,X.,et al, 2025

Collaboration on the Optimal Timing of Anticoagulation after Ischaemic Stroke and Atrial Fibrillation:A Systematic Review and Prospective Individual Participant Data Meta-Analysis of Randomised Controlled Trials (CATALYST)
Lancet 406:43-51, Dehbi,K-M.,et al, 2025

Outcomes of Patients with Embolic Stroke of Undetermined Source Treated with Antiplatelet Agents or Anticoagulation, A Multicenter Cohort Study
Neurol 105: e213876, Seigler,J.E.,et al, 2025

Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons with Dementia
Neurol 105: e213717, Zissimopoulos, J.,et al, 2025

A 27-Year-Old Man with Progressive Bilateral Vision Loss Resistant to Steroid Therapy
Neurol 105: e213897, Zhang,W.,et al, 2025

Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients with Atrial Fibrillation,A Systematic Review and Meta-Analysis
JAMA Neurol 82:696-705, McCabe,J.J.,et al, 2025

The Spectrum of Fragile X Disorders
NEJM 393:281-288, Hagerman,R.H. & Hagerman,P.J., 2025

Pan-Neurofascin Nodo-Paranodopathy Presenting as Fulminant Guillain-Barre Syndrome
Neurol 105:e213848, Cabral,A.,et al, 2025

Cerebral Air Embolism Caused by Atrial-Esophageal Fistula Following Left Atrial Ablation
Stroke 56:e195-e199, Masheyekhi,M.,et al, 2025

Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025

A 72-Year-Old Man with Progressive Pan-Dysautonomia
Neurol 105:e213994, Zelikovich,A.S.,et al, 2025

Frequency, Risk Factors, and Outcomes of Strokes in Patients with Primary Glioma After Cranial Radiation
Neurol 105:e213902, Ryan,D.,et al, 2025

Dejerine-Roussy Syndrome
Stat Pearls, Jan, Jahngir,M.U. & Qureshi,A.I., 2025

Risdiplam in Presymptomatic Spinal Muscular Atrophy
NEJM 393:671-682, Finkel,R.S.,et al, 2025

Endovascular Treatment in Acute Ischemic Stroke Due to Occlusion of Medium or Distal Vessels
Neurol 105:e214015, Palaiodimou,L.,et al, 2025

Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Neurol 105:e213903, Thakolwilboon,S.,et al, 2025

GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
JAMA Neurol 82:887-892, Sioutas,G.S.,et al, 2025

Emergent Carotid Artery Stenting in Patients with Acute Ischemic Stroke with Tandem Lesions, One-Year Follow-Up Results from the SECURIS Study
Neurol 105:e214067, Ezcurra-Diaz,G.,et al, 2025

AI in Neurology: Everything, Everywhere, all at One PRT 2:Speech, Sentience, Scruples, and Service
Ann Neurol 98:431-447, Rizzo, M., 2025

The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025

Unmasking Cerebrotendinous Xanthomatosis, Clinical Recognition of a Treatable Cause of Progressive Ataxia
Neurol 105:e214099, Mizutani,H.,et al, 2025

Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025

Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke
NEJM 393:1191-1201, Tao,C.,et al, 2025

Clinicopathologic Conference, Chagas Disease
NEJM 393:1216-1225, Case 27-2025, 2025

A 40-Year-Old Man With Refractory Status Epilepticus After Small Bowel Resection for Volvulus
Neurol 105:e214182, Chakravartty,A.,et al, 2025

Atypical Diabetic Neuropathies
BMJ 390:e081109, McCray,B.A.,et al, 2025

New Treatments for Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans
BMJ 390:e085564, Burch, R. & Rittenberg, E., 2025

Endovascular Therapy for Acute Vertebrobasilar Occlusion (VERITAS): A Systematic Review and Individual Patient Data Meta-Analysis
Lancet 405:61-69, Nogueira,R.G.,et al, 2025

Rocky Mountain Spotted Fever Encephalitis and "Starry Sky" Pattern on MRI, A Case Report
Neurologist 30:34-38, Mikhaiel,J.P.,et al, 2025

Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025

Acute Postradiation Lumbosacral Plexopathy
Neurol 103:e209972, Koropouli,E.,et al, 2024

Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease
Stroke 55:2632-2640, Poorthuis,M.H.F.,et al, 2024

Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024

Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024



Showing articles 350 to 400 of 10905 << Previous Next >>